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Purpose: To study the effect of subtoxic levels of hydrogen peroxide (H2O2) on the expression and release of interleukin-6
(IL-6) by cultured retinal pigment epithelial (RPE) cells and to explore the relevant signal pathways.
Methods: Cultured human RPE cells were stimulated with various subtoxic concentrations of H2O2 for different periods.
Conditioned medium and cells were collected. IL-6 in the medium and IL-6 mRNA in the collected cells were measured
using an IL-6 enzyme-linked immunosorbent assay kit and reverse transcriptase polymerase chain reaction, respectively.
Nuclear factor-kappaB (NF-κB) in nuclear extracts and phosphorylated p38 mitogen-activated protein kinase (MAPK),
extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinases (JNK) in cells cultured with and without
H2O2 were measured by NF-κB and MAPK enzyme-linked immunosorbent assay kits. Inhibitors of p38 (SB203580),
ERK (UO1026), JNK (SP600125), and NF-κB (BAY11–7082) were added to the cultures before the addition of H2O2 to
test their effects.
Results: Subtoxic levels of H2O2 (100 µM and less) increased the IL-6 mRNA level and the release of IL-6 protein by
the cultured human RPE cells in a dose- and time-dependent manner. This was accompanied by an increase of NF-κB in
nuclear extracts and phosphorylated p38 MAPK, ERK, and JNK in cell lysates, particularly in the p38 and NF-κB. The
NF-κB inhibitor decreased the H2O2-induced expression of IL-6. The p38 inhibitor, but not the ERK or JNK inhibitor,
completely abolished H2O2-induced expression of IL-6 by RPE cells. The p38 inhibitor also abolished the increase of NF-
κB in nuclear extracts in cells treated with H2O2.
Conclusions: H2O2 stimulated the production of IL-6, a key factor in the modulation of immune responses, inflammatory
processes, and the occurrence of autoimmune diseases, which recently has been documented to be increased in age-related
macular degeneration (AMD). This may be a molecular linkage for the oxidative stress and inflammatory/autoimmune
reactions in AMD and may provide a novel target for the treatment of AMD.
Age-related macular degeneration (AMD) is the leading
cause  of  blindness  among  elderly  persons  in  Western
countries  [1].  Oxidative  stress  has  been  implicated  in  the
pathogenesis  of  AMD.  Reactive  oxygen  species  (ROS)
generated from phagocytosis, lipid peroxidation, and photic
stress, together with the high oxygen tension in the choroid
and  in  the  macular  region,  contribute  to  the  particular
susceptibility  to  oxidative  stress  demonstrated  in  retinal
pigment epithelial (RPE) cells in the macular region [1-5].
ROS have two different effects on the cells. Traditionally,
they are thought to have cytotoxic effects and are implicated
in causing cell death; however, recent studies also suggest that
at subtoxic levels, they may influence signaling pathways and
play a major role in various aspects of cell function [6-9].
There has been increasing evidence suggesting a role for
inflammation,  aberrant  complement  activation,  and
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autoimmune responses in the pathogenesis of AMD [10-26].
It is therefore important to explore mechanisms involved in
ROS-induced inflammatory and autoimmune responses.
Interleukin-6 (IL-6) is a pro-inflammatory cytokine. It
amplifies immune and inflammatory responses and plays a
critical  role  in  the  occurrence  of  autoimmune  diseases
[27-30]. Elevated IL-6 levels have been observed in various
autoimmune diseases, including uveitis [31-33]. Recently, it
was  reported  that  serum  IL-6  levels  correlate  with  the
progression of AMD and high levels of serum IL-6 were
associated with the geographic atrophy type of AMD [13,
14].
Human RPE cells constitutively express and release IL-6
at a relatively low level [34-38]. Subtoxic levels of hydrogen
peroxide (H2O2) stimulate the production of IL-6 in several
cell  types  [39-43].  However,  the  effect  of  H2O2  on  the
production of IL-6 by RPE cells has not yet been reported.
We  hypothesized  that  subtoxic  levels  of  H2O2  may
stimulate the production of IL-6 by RPE cells, leading to the
stimulation of inflammatory and autoimmune reactions. They
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1864may  also  play  a  role  in  the  pathogenesis  of  AMD.  This
hypothesis was tested by evaluating the effect of H2O2 on the
production of IL-6 by RPE cells. Relevant signal pathways
were also studied.
METHODS
Cell culture: The human retinal pigment epithelial cell line
(ARPE-19),  was  obtained  from  American  Type  Culture
Collection, Manassas, VA. Cells were cultured in Dulbecco’s
modified  Eagle’s  medium  (Gibco,  Carlsbad,  CA)
supplemented with 10% fetal bovine serum (Gibco). Cells
were incubated in a humidified 5% CO2 atmosphere at 37 °C.
After reaching confluence, cells were detached by trypsin-
EDTA  solution  (Gibco),  diluted  1:3–1:4,  plated  for
subculture, and passaged routinely at a dilution of 1:3–1:4
every 5–7 days.
A new separate culture of primary human RPE cells was
isolated from a donor eye (56 years old) and cultured as
previously described [44]. Cells were cultured in Dulbecco’s
modified Eagle’s medium with 10% fetal bovine serum. After
reaching  confluence,  cells  were  subcultured  as  described
previously  [44].  Phase-contrast  microscopy  revealed
pigmentation of RPE cells during the primary culture and the
first and second subcultures. Cells displayed characteristic
epithelial  morphology  throughout  the  culture  period.  The
purity  of  the  cell  lines  was  demonstrated  by
immunocytochemical methods. RPE cells displayed positive
staining of cytokeratin, whereas fibroblasts and melanocytes
did  not  [45].  Cells  were  cultured  on  chamber  slides  and
immunostained  with  anti-cytokeratin  antibodies  (for
cytokeratin 6 and 18; Dako, Carpinteria, CA) as described
previously [45]. Immunocytochemical study showed that all
cells  stained  positively  with  anti-cytokeratin  antibody,
indicating the purity of the RPE cells.
Effects of hydrogen peroxide on the viability of retinal pigment
epithelial cells: The effects of H2O2 on the viability of RPE
cells  were  studied  with  a  3-(4,5-dimethylthiazol-2-yl)-2,5
diphenyltetrazolium bromide (MTT) test. Briefly, RPE cells
were plated in 96-well plates at a density of 5x103 cells per
well. After incubation for 24 h, H2O2 (Sigma, St. Louis, MO)
was added to the wells at various final concentrations (10, 30,
60, 100, and 300 µM) and cultured for 24 h. Then, 50 µl of
MTT (1 mg/ml, Sigma) was added to each well and incubated
for 4 h. The medium was withdrawn and 100 µl of dimethyl
sulfoxide (Sigma) was added to each well. The optical density
was read at 540 nm using a microplate reader (Multiskan EX,
Thermo, Vantaa, Finland). Cells cultured without H2O2 were
used as the controls. All groups were tested in triplicate.
Hydrogen  peroxide  treatment  and  interleukin-6  protein
measurement: RPE cells were plated into 24-well plates at a
density of 1×105 cells per well. After 24 h incubation, the
medium was withdrawn, and cells were washed with Hanks’
balanced saline solution (Gibco). Fresh medium with different
concentrations of H2O2 (0, 10, 30, 60, and 100 µM) was added
to the culture. After 24 h, the conditioned culture medium was
collected and centrifuged for 5 min to remove suspended cells.
Supernatants  were  collected  and  stored  at  −70  °C  until
analysis. In the time-dependent study, cells were cultured with
H2O2 (100 µM) for 2, 6, 12, and 24 h and then collected as
described above.
The amount of IL-6 protein in the conditioned medium
was determined using the human IL-6 Quantikine enzyme-
linked  immunosorbent  assay  (ELISA)  kit  (R&D  Systems,
Minneapolis,  MN)  according  to  the  manufacturer’s
instructions. Supernatants of condition media were added to
96 well plate precoated with monoclonal antibody against
IL-6 and incubated 2 h at room temperature. Conditioned
media  were  aspirated  and  wells  were  washed  with  Wash
Buffer  four  times.  Antibody  against  IL-6  conjugated  to
horseradish peroxidase was added to the well and incubated
2 h at room temperature. Wells were aspirated and washed
with Wash Buffer four times. Color Reagent A (H2O2) and B
(tetramethylbenzidine) were added and incubated for 20 min
at room temperature in darkness. Stop solution (sulfuric acid)
was added. IL-6 standard at various concentrations was tested
simultaneously.  Optical  density  was  read  by  using  a
microplate reader (Multiskan EX, Thermo, Vantaa, Finland)
at 450 nm. The amount of IL-6 (pg/ml) was calculated from
the standard curve. The sensitivity of this kit was 0.7 pg/ml.
All tests were performed in triplicate.
Hydrogen  peroxide  treatment  and  interleukin-6  mRNA
measurement: RPE cells were plated into 6-well plates at a
density of 8×105 cells per well. After 24 h incubation, the
medium was changed, and H2O2 was added to the medium at
a final concentration at 100 µM. After 2, 4, and 6 h, cells were
washed with cold phosphate-buffered saline (PBS; pH 7.4,
with components: potassium phosphate monobasic, 0.001 M;
sodium  chloride,  0.155  M  and  sodium  phosphate  dibasic,
0.003 M) three times and then scraped from the well. After
centrifugation at 400 xg for 5 min at 4 °C, the cell pellets were
collected and stored at −70 °C until analysis. In the dose-
dependent study, H2O2 was added to the medium at various
concentrations (0, 10, 30, and 100 µM). Cells were collected
and centrifuged 4 h later and stored at −70 °C.
Total RNA was isolated using the Qiagen RNeasy mini
kit following the manufacturer’s instructions. The purified
RNA was reverse-transcribed to single-stranded cDNA using
the SuperScript® First-Strand Synthesis System (Cat. No.
11904–018; Invitrogen, Carlsbad, CA). Primers for IL-6 and
GAPDH  were  designed  using  the  Primer3  program  as
previously described [46,47] (Table 1). Real-time PCR was
performed  in  triplicate  for  each  RNA  sample,  using  the
SYBR® Green PCR Master Mix (Cat. No.4309155, Applied
Biosystems, Carlsbad, CA) and primers for IL-6, GAPDH,
and beta-actin (ACTB). The PCR was cycled in a 7900HT
thermal  cycler  (Applied  Biosystems)  under  the  following
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60 °C for 20 s, and 72 °C for 30 s. Relative transcript quantities
were  determined  using  Sequence  Detection  Software
(Applied  Biosystems).  GAPDH  and  ACTB  were  used  as
references. All of these triplicate tests were assays for three
different specimens.
Hydrogen  peroxide  treatment  and  measurement  of
phosphorylated ERK, JNK, and p38 MAPK: RPE cells were
plated into 6-well plates at a density of 1×106 cells per well.
After 24 h incubation, the medium was changed, and H2O2 at
a final concentration of 100 µM was added to the medium.
After 30 min, the culture medium was withdrawn. Cells were
washed with cold PBS three times and then scraped from the
well. After cell counting and centrifugation at 400 xg for 5
min at 4 °C, the cell pellets were collected. Cells were lysed
using Cell Extraction Buffer (BioSource, Camarillo, CA) with
Protease  Inhibitor  Cocktail  (Sigma)  and
phenylmethylsulfonyl fluoride (BioSource), incubated on ice
for 30 min, and vortexed for 30 s. The lysates were centrifuged
at 17,500 xg for 10 min at 4 °C. The supernatants were stored
at −70 °C until analysis.
The amount of phosphorylated p38 mitogen-activated
protein  kinases  (MAPK),  extracellular-signal-regulated
kinase (ERK), and c-Jun N-terminal kinases (JNK) in cell
lysates were measured using ELISA kits (p38 MAPK kit,
#KHO0071;  ERK1/2  kit,  #KHO0091;  and  JNK1/2  kit,
#KHO0131;  Invitrogen,  Camarillo,  CA)  according  to  the
manufacturer’s instructions. The levels of phosphorylated p38
MAPK, ERK, and JNK were calculated using the standard
curve and expressed as units/ml (U/ml). One Unit of p38
MAPK is equivalent to the amount of p38 MAPK derived
from 40 pg of p38 MAPK which was phosphorylated by
MKK6. One Unit of ERK1/2 is equivalent to the amount of
ERK1/2  derived  from  40  pg  of  ERK1/2  which  was
phosphorylated by MEK1. One Unit of JNK1/2 is derived
from 50 pg of phosphorylated JNK1 or JNK2 (instructions of
p38  MAPK,  ERK1/2,  and  JNK1/2  ELISA  kits).  The
sensitivity of these kits was 0.8 U/ml. All tests were performed
in triplicate.
H2O2  treatment  and  measurement  nuclear  factor-kappaB
(NFκB) in nuclear extracts: RPE cells were plated into 6-well
plates  at  a  density  of  1×106  cells  per  well.  After  24  h
incubation, the medium was changed, and H2O2 at a final
concentration of 100 µM was added to the medium. After 30
min, the culture medium was withdrawn. Cells were washed
with cold PBS and then scraped from the well. Cells were
treated with hypotonic buffer (BioSource) and centrifuged.
The pellet (nuclear fraction) was collected and treated with
Cell Extraction Buffer (BioSource), vortexed, centrifuged,
and the supernatants (nuclear extracts) were stored at −70 °C
until analysis.
The amount of nuclear factor-kappaB (NF-κB) in cell
nuclear extracts was measured by using NF-κB ELISA kits
(#KHO0371,  Invitrogen)  according  to  the  manufacturer’s
instructions. The levels of NF-κB in nuclear extracts were
calculated using the standard curve and expressed as pg/ml.
The sensitivity of these kits was <50 pg/ml. All of these
triplicate tests were assays for three different specimens.
Effects  of  MAPK  and  NF-κB  inhibitors  on  H2O2-induced
release of IL-6 by RPE cells: RPE cells were plated into 24-
well plates at a density of 1×105 cells per well. After 24 h
incubation, the medium was changed, and various MAPK or
NF-κB  inhibitors  were  added  to  the  medium  separately,
including  5  µM  BAY11–7082  (NF-κB  inhibitor),  10  µM
UO1026 (ERK inhibitor), 10 µM SP600125 (JNK inhibitor),
and  10  µM  SB203580  (p38  MAPK  inhibitor),  all  from
Calbiochem, San Diego, CA. After 30 min, H2O2 was added
to the medium at a final concentration of 100 µM. After 24 h
incubation,  the  conditioned  medium  was  collected  and
centrifuged.  The  amount  of  IL-6  in  the  supernatant  was
determined using the human IL-6 Quantikine ELISA kit, as
described above. Cells cultured with medium without H2O2
were used as negative controls and cells cultured with H2O2
but without inhibitors were used as the positive controls. All
tests were performed in triplicate.
Effects of p38 inhibitors on H2O2-induced increase of NF-κB
in nuclear extracts: RPE cells were plated into 6-well plates
at a density of 1×106 cells per well. After 24 h incubation, the
medium was changed, and SB203580 (p38 MAPK inhibitor)
at a final concentration of 10 µM was added. After 30 min,
H2O2 at a final concentration of 100 µM was added to the
medium as described above. After another 30 min, the culture
medium was withdrawn. Cells were collected and the amount
of NF-κB in nuclear extracts was measured by using the NF-
κB ELISA kit, as described above. Cells cultured without
H2O2 and with H2O2 but without SB203580 were used as
negative  and  positive  controls,  respectively.  Tests  were
performed in triplicate.
TABLE 1. PRIMERS FOR IL-6 AND GAPDH.
Gene Accession number Primers (3′-5′) Product
IL-6 NM_000600 F: AGTGAGGAACAAGCCAGAGC 97 bp
    R: CAGGGGTGGTTATTGCATCT  
GAPDH M33197 F: CGACCACTTTGTCAAGCTCA 112 bp
    R: GGTGGTCCAGGGGTCTTACT  
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throughout this study were analyzed with one way ANOVA
with a Student-Newman-Kuels post hoc test. A difference at
p<0.05 and p<0.01 was considered to be significant and very
significant, respectively.
RESULTS
Effects of H2O2 on the viability of RPE cells: In RPE cells (both
ARPE-19 and the primary cultures) cultured with H2O2 at 10–
100 µM, the MTT assay showed no significant difference as
compared with cells cultured without H2O2, indicating that
H2O2 at 10–100 µM did not affect the viability of RPE cells.
Cell  viability  in  these  two  cell  lines  decreased  only  by
300 μM H2O2. Cell viability in ARPE-19 and the primary
cultures cultured with 300 μM H2O2 was 79.6±6% (mean
±standard deviation) and 81±5% of the controls (p=0.0218
and 0.0190), respectively. Therefore, H2O2 at 10–100 µM was
used to study the effects of subtoxic levels of H2O2 on the
expression and release of IL-6 from RPE cells.
Effects of H2O2 on the release of IL-6 by RPE cells: H2O2
increased the level of IL-6 protein in the culture medium of
ARPE-19 cells in a dose-dependent manner (Figure 1). IL-6
level  in  conditioned  medium  from  cells  cultured  without
H2O2 was 150.7±7.9 pg/ml (mean± standard deviation [SD]).
IL-6 levels in conditioned medium from cells cultured with
H2O2 at 10, 30, 60, and 100 µM were 1.05-fold, 1.22-fold,
1.52-fold, and 1.82-fold, respectively, of those of the controls
(Figure 1). IL-6 levels were not different comparing 0 and
10 μM H2O2 (p=0.5866). Compared 30 μM H2O2 there was a
difference (p=0.0169) and a larger difference 60 and 100 μM
H2O2 (p=0.0097 and 0.0005, respectively).
The  H2O2-induced  increase  of  release  of  IL-6  by
ARPE-19 cells was also time dependent (Figure 2). The IL-6
level  in  conditioned  medium  from  cells  cultured  without
H2O2  was  144.2±7.8  pg/ml.  IL-6  levels  in  conditioned
medium from cells cultured with H2O2 (100 µM) for 2, 6, 12,
and 24 h were 1.12-fold, 1.26-fold, 1.31-fold, and 1.82-fold
of the controls, respectively (Figure 2). IL-6 levels were not
different  comparing  0  and  100  μM  H2O2  treated  for  2  h
(p=0.1129).  Compared  after  6h  there  was  a  difference
(p=0.0269) and a larger difference after 12 and 24 h (p=0.0091
and 0.0009, respectively).
H2O2 also induced increased release of IL-6 by human
RPE cells isolated from a 56-year-old donor in a dose- and
time-dependent  manner.  The  IL-6  level  in  conditioned
medium from cells cultured without H2O2 was 132.1±9.6 pg/
ml. IL-6 levels were not different comparing 0 and 10 μM
H2O2 (p=0.6024). Compared 30 and 60 μM H2O2 there was a
difference (p=0.0456 and 0.0110, respectively) and a larger
difference 100 μM H2O2 (p=0.0005). IL-6 levels were not
different  comparing  0  and  100  μM  H2O2  treated  for  2  h
(p=0.1129).  Compared  after  6  h  there  was  a  difference
(p=0.0269) and a larger difference after 12 and 24 h (p=0.0091
and 0.0009, respectively).
Effects of H2O2 on IL-6 mRNA level in RPE cells: The real-
time PCR experiment demonstrated that H2O2 upregulated
IL-6 mRNA levels in RPE cells. In the time-dependent study,
the  expression  of  IL-6  in  H2O2-treated  cells  (100  µM)
increased to 1.57±0.04, 1.97±0.09, and 1.95±0.07 fold of the
controls after 2, 4, and 6 h treatments, respectively. In the
dose-dependent study, the IL-6 mRNA level in H2O2-treated
cells (10, 30, and 100 µM) increased to 1.21±0.04, 1.36±0.08,
and 1.97±0.09 fold of the controls, respectively, after 4 h
treatment. The difference in the IL-6 mRNA levels between
the  H2O2-treated  cells  (100  µM)  and  the  controls  was
significant (p=0.0189).
Effects of H2O2 on phosphorylated ERK, JNK, and p38 MAPK
level in RPE cells: H2O2 treatment (100 µM with 30 min
incubation) increased phosphorylated ERK, JNK, and p38
MAPK  levels  in  ARPE-19  cells  (Figure  3).  The  level  of
phosphorylated p38 MAPK in cells cultured without H2O2 was
81.2±11.0 U/ml and in H2O2 treated cells this increased to 3.19
fold  of  the  controls  (Figure  3B).  The  difference  in
phosphorylated p38 MAPK levels between cells treated with
and  without  H2O2  was  statistically  very  significant
(p=0.00003). The increase of phosphorylated ERK and JNK
levels in H2O2 treated cells was much less than that of p38.
Figure 1. The dose-dependent effects of subtoxic levels of hydrogen
peroxide on release of interleukin-6 by retinal pigment epithelium
cells. Retinal pigment epithelium (RPE) cells (ARPE-19) were plated
into  24-well  plates.  After  24  h  incubation,  hydrogen  peroxide
(H2O2, at 0, 10, 30, 60, and 100 µM) was added to the culture and
incubated for 24 h. Conditioned culture medium was collected and
the amount of interleukin-6 (IL-6) protein in the conditioned medium
was determined using the human IL-6 Quantikine enzyme-linked
immunosorbent assay (ELISA) kit. IL-6 levels in conditioned culture
medium  were  expressed  as  pg/ml  (mean±standard  deviation  in
triplicate  tests).  *0.01<  p<0.05,  **p<0.01,  compared  with  the
controls (cells cultured without H2O2).
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without H2O2 were 28.2±2.3 and 74.5±5.7 U/ml, respectively.
The level of phosphorylated ERK and JNK in H2O2-treated
cells only increased to 1.56 and 1.28 fold of the controls,
respectively (Figure 3C,D). The difference in phosphorylated
ERK and JNK levels between cells treated with and without
H2O2  was  statistically  significant  (p=0.0315  and  0.0177,
respectively).
Effect of H2O2 on NF-κB levels in nuclear extracts from RPE
cells:  H2O2  treatment  (100  µM  with  30  min  incubation)
increased NF-κB levels in nuclear extracts from ARPE-19
cells (Figure 3A). The levels of NF-κB in nuclear extracts in
cells cultured with and without H2O2 were 318.7±54.4 U/ml
and  152.3±15.6  U/ml,  respectively  (Figure  3A).  The
difference of NF-κB levels between cells treated with and
without H2O2 was statistically very significant (p=0.0012).
Effects  of  MAPK  and  NF-κB  inhibitors  on  H2O2-induced
increase of IL-6 release by RPE cells: Treatment of ARPE-19
cells with SB203580 (p38 MAPK inhibitor) 30 min before the
H2O2 addition completely abolished H2O2-induced release of
IL-6  (Figure  4).  The  difference  in  the  amount  of  IL-6  in
medium between cells treated with and without SB203580
(positive control) was very significant (p=0.0022). The level
of IL-6 in medium from SB203580 and H2O2 treated cells was
similar to that of negative controls (cells cultured without
Figure 2. The time-dependent effects of subtoxic levels of hydrogen
peroxide on release of interleukin-6 by retinal pigment epithelium
cells. Retinal pigment epithelium (RPE) cells (ARPE-19) were plated
into  24-well  plates.  After  24  h  incubation,  100  µM  hydrogen
peroxide (H2O2) was added to the culture and incubated for 2, 6, 12,
and 24 h. Conditioned culture medium was collected and the amount
of  interleukin-6  (IL-6)  protein  in  the  conditioned  medium  was
determined  by  using  the  human  IL-6  Quantikine  enzyme-linked
immunosorbent assay (ELISA) kit. IL-6 levels in conditioned culture
medium  were  expressed  as  pg/ml  (mean±standard  deviation  in
triplicate  tests).  *0.01<  p<0.05,  **p<0.01,  compared  with  the
controls (cells cultured without H2O2).
H2O2, p=0.0947). These results indicated that the p38 inhibitor
(SB 203580) completely abolished the H2O2-induced increase
of release of IL-6 by RPE cells.
Pretreatment of ARPE-19 cells with BAY11–7082 (NF-
κB inhibitor) 30 min before the H2O2 addition decreased 72%
of H2O2-induced release of IL-6 (Figure 4). The difference in
the amount of IL-6 in medium between ARPE-19 cells treated
with  and  without  BAY11–7082  (positive  control)  was
significant (p=0.0232). The levels of IL-6 in medium from
BAY11–7082 and H2O2 treated cells was slightly greater than
that  of  negative  controls  (cells  cultured  without  H2O2);
however, there was no significant difference between these
two groups (p=0.1155), indicating that the NF-κB inhibitor
inhibited the H2O2-induced increase of the release of IL-6 by
RPE cells.
Treatment with UO1026 (ERK inhibitor) and SP600125
(JNK inhibitor) 30 min before the H2O2 addition only showed
a minor influence on the H2O2-induced release of IL-6 by
ARPE-19 cells (Figure 4). The IL-6 levels in conditioned
media from cells cultured with UO1026 or SP600125 were
similar to that of cells treated with H2O2 (positive control).
Figure 3. The effects of subtoxic levels of hydrogen peroxide on
nuclear factor factor-kappaB in nuclear extracts and phosphorylated
extracellular signal-regulated kinases, c-Jun N-terminal kinase and
p38 mitogen-activated protein kinase. Retinal pigment epithelium
(RPE) cells (ARPE-19) were plated into 24-well plates. After 24 h
incubation, 100 µm hydrogen peroxide (H2O2) was added to the
medium. Cells were collected 30 min later. The nuclear factor factor-
kappaB (NF-κB) levels in nuclear extracts (A) and phosphorylated
p38 mitogen-activated protein kinase (p38; B), c-Jun N-terminal
kinase (JNK; C) and extracellular signal-regulated kinases (ERK;
D) in cell lysates were measured using the relevant NF-κB enzyme-
linked  immunosorbent  assay  (ELISA)  kit  and  phosphorylated
MAPK ELISA kits (Biosource). The levels of NF-κB in nuclear
extracts were expressed as pg/ml and phosphorylated p38, ERK and
JNK  in  cell  lysates  were  expressed  as  U/ml  (mean±standard
deviation in triplicate tests). *0.01< p<0.05, **p<0.01, compared
with the controls (cells cultured without H2O2).
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between cells treated with or without UO1026 (p=0.4202) and
cells treated with or without SP600125 (p=0.8917).
Effects of p38 inhibitor on the H2O2-induced increase of NF-
κB in nuclear extracts: NF-κB levels in nuclear extracts from
cells cultured without H2O2, with H2O2, and with H2O2 and p38
inhibitor  were  146±13.5,  323±21.9,  and  152.7±7.8  pg/ml,
respectively. The difference of NF-κB levels between cells
cultured without H2O2 and with H2O2 and p38 inhibitor was
non-significant (p=0.6208) and the difference between cells
cultured with H2O2 and H2O2 and p38 inhibitor was very
significant (p=0.002). This indicated that the increase of NF-
κB  levels  in  nuclear  extracts  induced  by  H2O2  could  be
completely abolished by the p38 inhibitor.
DISCUSSION
There  has  been  increasing  evidence  suggesting  a  role  for
inflammation  and  aberrant  complement  activation  in  the
pathogenesis  of  AMD  [10-26].  Chronic  inflammatory
infiltrates have been demonstrated in the choroid and excised
choroidal  neovascular  membranes  (CNV)  from  AMD  [5,
Figure  4.  Effects  of  nuclear  factor  factor-kappaB  and  mitogen-
activated protein kinase inhibitors on the hydrogen peroxide-induced
production  of  interleukin-6  by  retinal  pigment  epithelium  cells.
Retinal pigment epithelium (RPE) cells (ARPE-19) were plated into
24-well plates. After 24 h incubation, various mitogen-activated
protein  kinase  (MAPK)  and  nuclear  factor-kappaB  (NF-κB)
inhibitors were added to the medium separately, including BAY11–
7082  (NF-κB  inhibitor),  UO1026  (extracellular  signal-regulated
kinases inhibitor), SP600125 (c-Jun N-terminal kinase inhibitor) and
SB203580 (p38 MAPK inhibitor, all from Calbiochem) at a final
concentration of 10 µM with the exception of BAY11–7082 (5 µM).
After 30 min, 100 µM hydrogen peroxide (H2O2) was added to the
medium. Cells cultured without H2O2 were used as negative controls.
Cells cultured with H2O2 but without inhibitors were used as positive
controls. After 24 h incubation, the culture medium was collected
and the IL-6 levels were measured with the human IL-6 Quantikine
ELISA  kit  and  expressed  as  pg/ml  (mean±standard  deviation  in
triplicate  tests).  *0.01<  p<0.05,  **p<0.01,  compared  with  the
positive controls (cells cultured with H2O2 but without inhibitors).
10-12,18,19].  Analyses  of  drusen  composition  in  AMD
patients  and  animal  models  have  identified  various
inflammatory proteins (e.g., acute phase proteins, cytokines,
etc.), immunoglobulin, and components of the complement
cascade [5,10-12,18,19]. Complement factor H (CFH), a key
inhibitor of the alternative pathway of complement activation,
can bind and inactivate harmful complement components and
prevent damage of intact host cells. CFH gene polymorphism
has been reported to be an important risk factor for AMD.
Dysfunction of the complement system may result in local
inflammation, autoimmune reactions, and tissue damage, and
may play an important role in the etiology of AMD [11,12,
15,17,20].
There  are  several  possibilities  linking  ROS  and
inflammatory processes in AMD. ROS may cause damage of
RPE cells and result in cell debris deposits between the RPE
and  Bruch’s  membrane,  which  may  in  turn  induce  an
inflammatory reaction [5,10-12]. Prolonged phagocytosis of
oxidized  photoreceptor  outer  segments  may  reduce  the
production of CFH, which could lead to overactivation of
complement cascades [21]. Immunization with an oxidant
product of docosahexaenoic acid in the retina produced AMD-
like lesions in mice [22].
IL-6  is  the  key  factor  for  the  stimulation  of  immune
reactions,  inflammatory  processes,  and  the  occurrence  of
autoimmune diseases [27-30]. Increased systemic or local
IL-6  levels  have  been  observed  in  various  autoimmune
diseases [27-33]. IL-6–deficient mice are resistant to various
experimentally induced autoimmune diseases [28,29].
IL-6 also plays a role in inflammatory processes. At the
beginning of inflammation, IL-6 mediates the acute phase
response. It stimulates the production of various acute phase
proteins  (C-reactive  protein,  α-antitrypsin,  α-
antichymotrypsin, fibrinogen, etc., most of which are present
in drusen) by cells to cause a systemic reaction and local
inflammation [30]. IL-6 synergistically induces production of
VEGF by cells with IL-1 or TNF-α [48]. IL-6 decreases the
synthesis  of  CFH  by  RPE  cells,  which  may  result  in  the
overactivation  of  complement  cascades,  inflammatory
processes, and autoimmune reactions [21].
Seddon et al. [14] reported that plasma IL-6 levels were
related to the progression of AMD. In a population-based
multi-ethnic  study  involving  5,887  persons,  Klein  et  al.
reported  that  increased  IL-6  plasma  levels  are  definitely
associated with geographic atrophy (odds ratio: 2.06, 95%
confidence interval, 1.21–3.49) [13]. Aqueous humor IL-6
level is correlated with the size of CNV in activate CNV
patients,  indicating  that  IL-6  level  may  be  related  to  the
progression of CNV [49].
ROS were first considered only as cytotoxic substances
that induce cell death at high concentrations. In the past few
years,  however,  they  have  gained  attention  as  potential
signaling molecules at subtoxic levels. ROS at physiologic
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[6-9]. Actually, in the pathological process of AMD, death of
RPE cells (geographic atrophy) occurs only at a later stage
[50]. Therefore, studying the effect of subtoxic levels of ROS
on the function of RPE cells is important for the elucidation
of early pathologic processes in AMD.
H2O2 is a relatively weak oxidant, but in the presence of
metal catalysts it can be converted to the reactive hydroxyl
radical, which is cytotoxic and can cause cell death. H2O2 is
the most stable ROS, so that it is present in tissues with a
relatively long half-life. H2O2 is soluble in both lipid and
aqueous media, and therefore it easily diffuses in and out of
the cell to reach targets. Subtoxic levels of H2O2 can influence
signaling  pathways  and  induce  changes  in  various  cell
functions [6-9]. H2O2 has been used as a model of exogenous
oxidative stress for testing both cytotoxic and nontoxic effects
on ocular cells [50-56]. The RPE is continuously exposed to
high  oxygen  fluxes  because  of  its  location  between  the
photoreceptors and choroid (where there is a high oxygen
partial pressure from the underlying choriocapillaris), and has
a high metabolic activity. A high level of oxidative stress
occurs in RPE cells, causing higher levels of H2O2. During
photoreceptor phagocytosis, RPE cells generate H2O2, which
can promote endogenous oxidative stress [3,5,51].
Recently, it has been reported that subtoxic levels of
H2O2  stimulate  the  expression  and  release  of  IL-6  in
fibroblasts, mast cells, skeletal myocytes, and trabecular cells
[39-43], but not in glioma cells or bronchial epithelial cells
[57,58]. This indicates that this effect is highly cell type–
specific. RPE cells constitutively express and release IL-6
[34-38]. However, the effects of H2O2 on the expression and
release of IL-6 by RPE cells was unknown in previous studies.
In the present study, subtoxic levels of H2O2 (30–100 µM)
stimulated the expression and secretion of IL-6 by human RPE
cells in vitro. These levels are compatible with that observed
during phagocytosis of the outer segments of photoreceptors
by RPE cells. It has been reported that H2O2 generated by RPE
cells  during  phagocytosis  and  the  degradation  of
photoreceptor outer segments can reach 29–40 µM after 4 h
exposure [51].
MAPK signaling pathways represent one of the most
important  pathways  influenced  by  H2O2  [6].  This  family
mainly consists of ERK1/2, JNK, and p38 kinase pathways.
In previous studies, H2O2 stimulated the production of IL-6 in
rat fibroblasts and myocytes through the activation of p38,
JNK, or ERK signaling pathways, mainly through the p38
pathway [39,42].
In the present study, H2O2 at subtoxic levels increased
phosphorylated  p38  MAPK  levels  in  RPE  cells.  A  p38
inhibitor could completely abolish the H2O2-induced increase
of IL-6 release by RPE cells, indicating that the stimulation
of  IL-6  production  in  RPE  cells  by  H2O2  mainly  occurs
through the activation of the p38 signaling pathway, which is
consistent with previous studies on other cell types [39,42].
In this study, H2O2 induced an increase of NF-κB levels
in nuclear extracts. An NF-κB inhibitor decreased the H2O2-
induced increase of IL-6 release by RPE cells, indicating that
NF-κB is involved in the H2O2-induced expression of IL-6. A
p38 inhibitor completely abolished the H2O2-induced increase
of NF-κB levels in nuclear extracts, indicating that H2O2-
induced NF-κB activation is dependent on p38 activation.
H2O2  activates  the  p38  signal  pathway,  which  leads  to
activation and translocation of NF-κB to the nuclei and in turn
leads to an increased release of IL-6. This is consistent with
the results of previous studies, which showed that NF-κB
activation in various cell lines via different stimulators is
blocked by the p38 inhibitor, and that NF-κB activation is
dependent on p38 phosphorylation [59-64].
The  present  study  found  that  H2O2  stimulated  the
production of IL-6, a key factor in the modulation of immune
responses,  inflammatory  processes,  and  the  occurrence  of
autoimmune diseases, which recently has been documented
to be increased in AMD. This could be a molecular linkage
for  the  oxidative  stress  and  inflammatory/autoimmune
reactions in AMD, and may provide a novel target for the
treatment of AMD.
Recently,  progress  on  the  understanding  of  IL-6
pathobiology and its role in autoimmune reactions has led to
the improvement in the treatment of autoimmune diseases
using novel anti-IL-6 drugs [27,28,65,66]. The future perhaps
lies in the development of orally active small molecules that
inhibit specific inflammatory signaling pathways, e.g., the
inhibitor of p38 and its upstream effectors have been proven
to be effective in the treatment of autoimmune arthritis in a
rat  model  and  have  been  recently  tested  in  clinical  trials
[67-70].  These  novel  therapeutic  strategies  may  have  a
beneficial effect in the prevention and control of AMD and
warrant further investigation.
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